Healthcare -
Biotechnology - NASDAQ - US
$ 9.5
0.849 %
$ 968 M
Market Cap
-1.74
P/E
NTLA - TOTAL RECEIVABLES
Total Receivables NTLA - Intellia Therapeutics, Inc.
36.5 M
LAST VALUE
323.67%
2 YEAR CAGR
37.02%
5 YEAR CAGR
0.00%
10 YEAR CAGR